Insider Trading & Ownership of AI ETI LLC

Location
New York, NY
Summary
The estimated value of insider holdings of AI ETI LLC is at least $62,617,500 dollars as of 16 Aug 2021. AI ETI LLC is the 10%+ Owner of Eliem Therapeutics, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $62.62M.
Signature
/s/ Alejandro Moreno for AI ETI LLC
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow AI ETI LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • AI ETI LLC has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $62,617,500.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Eliem Therapeutics, Inc. ($62,617,500).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of AI ETI LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLYM Eliem Therapeutics, Inc. 10%+ Owner $62,617,500 12 Aug 2021

Insider Transactions Reported by AI ETI LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .